NRx Pharmaceuticals

NRx Pharmaceuticals Reports Minutes of Recent U.S. Food and Drug Administration (FDA) Meeting on the Development of NRX-101

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently reported the minutes of a Type B meeting with the U.S. Food and Drug Administration’s Division of Psychiatry Products held on January 11, …

NRx Pharmaceuticals Reports Minutes of Recent U.S. Food and Drug Administration (FDA) Meeting on the Development of NRX-101 Read More
Galera Therapeutics

Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted priority review to the New Drug Application …

Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis Read More